+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-01-08Number of Pages: 86

Foot and Mouth Disease Vaccines Market (Types- Conventional (Aluminum Hydroxide/Saponin and Oil Based Vaccines) and Emergency Vaccines; Application- Cattle, Pigs, Sheep and Goat and Others - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Foot and mouth disease (FMD) is a highly contagious disease that has significant economic impact. Virus named, Aphthovirus of the family Picornaviridae causes foot and mouth disease. Seven different types of strains namely O, A, C, Southern African Territories (SAT) 1, SAT 2, SAT 3 and Asia1 of Aphthovirus cause FMD in livestock. Outbreak of FMD causes negative impact on the economy of the country owing to resulting losses in milk and meat production industry. Therefore, governments of FMD endemic countries are aiming to eradicate the disease from the country by creating awareness about the disease. Increasing awareness is resulting in augmenting the adoption of routine vaccination of the livestock in FMD endemic countries. Therefore, rising awareness coupled with growing FMD outbreaks are the major factors driving the FMD vaccines market globally.  
 
Presently, two major types of vaccines namely, conventional vaccines and emergency vaccines are available in the market. In 2013, oil based FMD vaccines which is one of the sub-segment of conventional vaccine segment accounted for the largest market share in the global FMD vaccines market. Further, increasing adoption of routine vaccination strategy to eradicate or control the disease spread is anticipated to fuel the growth of conventional vaccines market during the forecast period. 
 
FMD vaccines have application in cattle, pigs, goat and sheep and other animals since; the disease mainly affects cloven hoofed animals. Other animals include some species of camels, elephants, deer and giraffe. Cattle segment accounted for the largest market share in the year 2013 owing to the presence of large number of cattle worldwide. Furthermore, rising dependency on animal proteins such as milk and meat is anticipated to drive the growth of the cattle segment during the forecast period from 2014 to 2020. 
 
 
Presently, Asia Pacific is leading the global FMD vaccines market owing to presence of major FMD endemic countries such as China, India, Hong Kong, South Korea, Pakistan, and Bangladesh. Furthermore, the FMD vaccines market in major countries in Rest of the World (Brazil and Egypt) and countries in Africa (mainly Sudan) are expected to witness rapid growth in the near future. Growth of the FMD vaccines market in Rest of the World (RoW) is attributed to frequent outbreaks of FMD in the region. North America, Australia, New Zealand and majority of Western European countries are FMD free countries with no vaccination. As a result, FMD vaccines market is anticipated to have low or no growth potential in these countries during the forecast period from 2014 to 2020. 
 
FMD vaccines market is a fragmented market with many local players competing with global players. In addition, governments of many FMD endemic countries have their own vaccine manufacturing facilities which are restraining the growth of the global players present in the market. Therefore, major market players aim to expand their regional reach and product portfolio by mergers and acquisitions of small and local players. In addition, major players are also trying to enter FMD endemic countries to expand geographically and thereby expand their market share in the global market. For instance, in October 2013, Biogenesis Bago, Argentina based FMD vaccine manufacturer received approval from the Chinese health department to install a FMD vaccine production unit named Yangling JINHAI Biotechnology Co in the Shaanxi province. This move would help Biogenesis Bago to enhance its product offerings in Asia and thereby expand its geographic presence. 
 

 
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
     1.3.1 Sources
             1.3.1.1 Secondary Research
             1.3.1.2 Primary Research
     1.3.2 Assumptions
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global FMD Vaccines Market (2013 and 2020)
2.2 Global FMD Vaccines Market Revenue, by Types, 2013 (USD Million)
2.3 Global FMD Vaccines Market Revenue, by Applications, 2013 (USD Million)
2.4 Comparative Analysis: Global FMD Vaccines Market, by Geography, 2013 & 2020 (Value %)
 
Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
     3.2.1 Favorable government initiatives boosts the demand of FMD vaccines
     3.2.2 Increasing consumption of meat and dairy products augments the demand of FMD vaccines
3.3 Market Restraints
     3.3.1 Government involvement in purchase of the vaccines result in reduction of cost
     3.3.2 Unpredictable serotype outbreaks limit the growth of the market
3.4 Market Opportunities
     3.4.1 DNA vaccines hold immense potential for foot and mouth disease
3.5 Regulatory Framework: Global FMD Vaccines Market
3.6 Value Chain Analysis: Global FMD Vaccines Market
3.7 Porter’s Five Forces Analysis: Global FMD Vaccines Market
     3.7.1 Bargaining power of suppliers
     3.7.2 Bargaining power of buyers
     3.7.3 Threat of substitutes
     3.7.4 Threat of new entrants
     3.7.5 Competitive rivalry
3.8 Market Attractiveness Analysis: Global FMD Vaccines Market, by Geography, 2013
3.9 Competitive Landscape
     3.9.1 Market Share Analysis: Global FMD Vaccines Market Share, by Key Players, 2013 (%)
 
Chapter 4 FMD Vaccines Market, by Types
4.1 Overview
     4.1.1 Global FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
4.2 Conventional Vaccines
     4.2.1 Global Conventional Vaccines Market Revenue, by Adjuvants, 2012 – 2020 (USD Million)
     4.2.2 Aluminum Hydroxide/Saponin based Vaccines
             4.2.2.1 Global Aluminum Hydroxide/Saponin based Vaccines Market, 2012 – 2020 (USD Million)
     4.2.3 Oil based Vaccines
             4.2.3.1 Global Oil based Vaccines Market, 2012 – 2020 (USD Million)
4.3 Emergency Vaccines
     4.3.1 Global Emergency Vaccines Market, 2012 – 2020 (USD Million)
 
Chapter 5 FMD Vaccines Market, by Applications
5.1 Overview
     5.1.1 Global FMD Vaccines Market Revenue, by Applications, 2012 – 2020 (USD Million)
5.2 Cattle
     5.2.1 Global Cattle Application Market, 2012 – 2020 (USD Million)
5.3 Pigs
     5.3.1 Global Pigs Application Market, 2012 – 2020 (USD Million)
5.4 Sheep and Goats
     5.4.1 Global Sheep and Goats Application Market, 2012 – 2020 (USD Million)
5.5 Others
     5.5.1 Global Others Application Market, 2012 – 2020 (USD Million)
 
Chapter 6 FMD Vaccines Market, by Geography
6.1 Overview
     6.1.1 Global FMD Vaccines Market Revenue, by Geography, 2012 - 2020 (USD Million)
6.2 North America
6.3 Europe
     6.3.1 Europe FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
6.4 Asia Pacific
     6.4.1 Asia Pacific FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
     6.4.2 Asia Pacific FMD Vaccines Market Revenue, by Country, 2012 - 2020 (USD Million)
     6.4.3 China
             6.4.3.1 China FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
     6.4.4 India
             6.4.4.1 India FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
     6.4.5 South Korea
             6.4.5.1 South Korea FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
     6.4.6 Malaysia
             6.4.6.1 Malaysia FMD Vaccines Market Revenue, by Country, 2012 - 2020 (USD Million)
     6.4.7 Rest of APAC
             6.4.7.1 Rest of APAC FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
6.5 Rest of the World (RoW)
     6.5.1 RoW FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
     6.5.2 RoW FMD Vaccines Market Revenue, by Country, 2012 - 2020 (USD Million)
     6.5.3 Latin America
             6.5.3.1 Latin America FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
     6.5.4 Africa
             6.5.4.1 Africa FMD Vaccines Market Revenue, by Country, 2012 - 2020 (USD Million)
             6.5.4.2 South Africa
                       6.5.4.2.1 South Africa FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
             6.5.4.3 Algeria
                       6.5.4.3.1 Algeria FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
             6.5.4.4 Nigeria
                       6.5.4.4.1 Nigeria FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
             6.5.4.5 Rest of Africa
                       6.5.4.5.1 Rest of Africa FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
     6.5.5 Rest of RoW
             6.5.5.1 Rest of RoW FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
 
Chapter 7 Recommendations
7.1 Investing in emerging economies
7.2 Long-term contracts with governments to expand market share
 
Chapter 8 Company Profiles
8.1 Agrovet Co.
     8.1.1 Company Overview
     8.1.2 Financial Overview
     8.1.3 Product Portfolio
     8.1.4 Business Strategies
8.2 Bayer AG
     8.2.1 Company Overview
     8.2.2 Financial Overview
     8.2.3 Product Portfolio
     8.2.4 Business Strategies
             8.2.4.3 Recent Developments
8.3 Biogenesis Bago
     8.3.1 Company Overview
     8.3.2 Financial Overview
     8.3.3 Product Portfolio
     8.3.4 Business Strategies
     8.3.5 Recent Developments
8.4 Brilliant Bio Pharma Limited
     8.4.1 Company Overview
     8.4.2 Financial Overview
     8.4.3 Product Portfolio
     8.4.4 Business Strategies
8.5 Indian Immunologicals Ltd.
     8.5.1 Company Overview
     8.5.2 Financial Overview
     8.5.3 Product Portfolio
     8.5.4 Business Strategies
8.6 Inova Biotecnologia
     8.6.1 Company Overview
     8.6.2 Financial Overview
     8.6.3 Product Portfolio
     8.6.4 Business Strategies
     8.6.5 Recent Developments
8.7 Intervac (Pvt.) Ltd.
     8.7.1 Company Overview
     8.7.2 Financial Overview
     8.7.3 Product Portfolio
     8.7.4 Business Strategies
8.8 Merial
     8.8.1 Company Overview
     8.8.2 Financial Overview
     8.8.3 Product Portfolio
     8.8.4 Business Strategies
     8.8.5 Recent Developments
8.9 Merck Animal Health
     8.9.1 Company Overview
     8.9.2 Financial Overview
     8.9.3 Product Portfolio
     8.9.4 Business Strategies
     8.9.5 Recent Developments

List of Figures
 
FIG. 1 FMD Vaccines: Market Segmentation
FIG. 2 Global FMD Vaccines Market Revenue, by Types, 2013 (USD Million)
FIG. 3 Global FMD Vaccines Market Revenue, by Applications, 2013 (USD Million)
FIG. 4 Comparative Analysis: Global FMD Vaccines Market, by Geography, 2013 & 2020 (Value %)
FIG. 5 Value Chain Analysis: Global FMD Vaccines Market
FIG. 6 Porter’s Five Forces Analysis: Global FMD Vaccines Market
FIG. 7 Market Attractiveness Analysis: Global Facial Injectables Market, by Geography
FIG. 8 Market Share Analysis: Global FMD Vaccines Market, by Key Players, 2013 (%)
FIG. 9 Global Aluminum Hydroxide/Saponin based Vaccines Market, 2012 – 2020 (USD Million)
FIG. 10 Global Oil based Vaccines Market, 2012 – 2020 (USD Million)
FIG. 11 Global Emergency Vaccines Market, 2012 – 2020 (USD Million)
FIG. 12 Global Cattle Application Market, 2012– 2020 (USD Million)
FIG. 13 Global Pigs Application Market, 2012– 2020 (USD Million)
FIG. 14 Global Sheep and Goats Application Market, 2012– 2020 (USD Million)
FIG. 15 Global Others Application Market, 2012– 2020 (USD Million)
FIG. 16 Bayer AG (Animal Health): Annual Revenue, 2011 – 2013 (USD Million)
FIG. 17 Merial (Animal Health Division of Sanofi): Annual Revenue, 2011 – 2013 (USD Million)
FIG. 18 Merck Animal Health: Annual Revenue, 2011 – 2013 (USD Million)

List of Tables
 
TABLE 1 Market Snapshot: Global FMD Vaccines Market (2013 and 2020)
TABLE 2 Global FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 3 Global Conventional Vaccines Market Revenue, by Adjuvants, 2012 – 2020 (USD Million)
TABLE 4 Global FMD Vaccines Market Revenue, by Applications, 2012 – 2020 (USD Million)
TABLE 5 Global FMD Vaccines Market Revenue, by Geography, 2012 – 2020 (USD Million)
TABLE 6 Europe FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 7 Asia Pacific FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 8 Asia Pacific FMD Vaccines Market Revenue, by Country, 2012 – 2020 (USD Million)
TABLE 9 China FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 10 India FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 11 South Korea FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 12 Malaysia FMD Vaccines Market Revenue, by Country, 2012 – 2020 (USD Million)
TABLE 13 Rest of APAC FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 14 RoW FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 15 RoW FMD Vaccines Market Revenue, by Country, 2012 – 2020 (USD Million)
TABLE 16 Latin America FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 17 Africa FMD Vaccines Market Revenue, by Country, 2012 – 2020 (USD Million)
TABLE 18 South Africa FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 19 Algeria FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 20 Nigeria FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 21 Rest of Africa FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 22 Rest of Row FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)

 
Foot-and-mouth disease (FMD) is an infection caused by aphthovirus belonging to the family Picornaviridae. FMD is caused by seven different types of serotypes: O, A, C, Asia 1 and Southern African Territories (SAT) 1, 2 and 3. Currently available vaccines are serotype-specific, hence multiple vaccinations are required to cover the antigenic diversity. Cloven-hoofed animals especially cattle, pigs, sheep and goats are susceptible to FMD. The major symptoms of FMD are high fever, sudden weight loss, increased death rate in newborn animals, low conception rate, painful lesions in and around mouth, lips and feet, and excessive salivation. High frequency of FMD outbreaks especially in Asia, the Middle East, and Latin America is fueling the demand for FMD vaccines. In addition, government initiatives to eradicate the disease is resulting in increased awareness about FMD vaccines, thereby driving market growth. This report covers the market analysis of various types of vaccines that are used to control FMD.
 
The executive summary of the report comprises market snapshot of the global foot-and-mouth disease vaccines market and comparative analysis by geography in terms of value % for 2013 and 2020. The global foot-and-mouth disease vaccines market has been segmented based on types of vaccines: conventional and emergency vaccines. The conventional vaccines segment has been sub-segmented based on adjuvants: aluminum hydroxide/saponin and oil-based vaccines. In-depth market analysis and forecast for all the segments mentioned above has been provided in the report, in terms of market revenue (USD million) from 2012 to 2020. The report includes the compounded annual growth rate (CAGR %) for each application segment (cattle, pigs, sheep and goat and others) for the forecast period from 2014 to 2020, considering 2013 as the base year.  
 
The market overview section of the foot-and-mouth disease vaccines market report analyzes the market dynamics and trends such as drivers, restraints and opportunities that influence the current nature and future status of the global FMD vaccine market. Impact factors such as market attractiveness analysis by geography and Porter’s five forces (bargaining power of suppliers, bargaining power of buyers, threat of new entrants, threat of substitutes and competitive rivalry) analysis of the global foot-and-mouth disease vaccines market have been provided in this section of the report. In addition, market share analysis of key players (value %) for the year 2013 has also been explained in the market overview section of the report in order to provide a thorough analysis of the overall competitive scenario in the global FMD vaccines market. Furthermore, the report includes value chain analysis and regulatory framework analysis of the FMD vaccines market. 
 
Geographically, the global FMD vaccines market has been classified into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW). The current and future market sizes (in terms of USD million) of the regional markets mentioned above have been provided in the report for the period from 2012 to 2020 along with the growth rate (CAGR %) for the period from 2014 to 2020. The study further offers recommendations for the foot-and-mouth disease vaccines market, which would be useful for existing and new players to sustain and grow in the market. 
 
The foot-and-mouth disease vaccines market report concludes with the company profiles section that includes key information in terms of company overview, financial information, product portfolio, business strategies and recent development about the major players operating in the FMD vaccines market. Detailed analysis of these companies is included in this section in order to give a thorough analysis of the overall competitive scenario in the global FMD vaccines market. Key players profiled in the section include Agrovet Co., Bayer AG, Biogenesis Bagó, Brilliant Bio Pharma Limited, Indian Immunologicals Ltd., Inova Biotechnologia, Intervac (Pvt.) Ltd., Merial, and Merck Animal Health (MSD). 
 
The global foot and mouth disease vaccines market is segmented as follows:
 
Global Foot and Mouth Disease Vaccines Market, by Types
  • Conventional Vaccines 
    • Aluminum Hydroxide/Saponin
    • Oil Based
  • Emergency Vaccines
Global Foot and Mouth Disease Vaccines Market, by Applications
  • Cattle
  • Pigs
  • Sheep and Goats
  • Others
Global Foot and Mouth Disease Vaccines Market, by Geography
  • North America
  • Europe 
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Malaysia
    • Rest of APAC
  • Rest of the World
    • Latin America
    • Africa
      • South Africa
      • Algeria
      • Nigeria
      • Rest of Africa
    • Rest of RoW